Stress cardiomyopathy cost-effectiveness of therapy

Revision as of 13:02, 28 August 2012 by Aditya Govindavarjhulla (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Stress cardiomyopathy Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stress Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy

Future or Investigational Therapies

Case Studies

Case #1

Stress cardiomyopathy cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stress cardiomyopathy cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stress cardiomyopathy cost-effectiveness of therapy

CDC on Stress cardiomyopathy cost-effectiveness of therapy

Stress cardiomyopathy cost-effectiveness of therapy in the news

Blogs on Stress cardiomyopathy cost-effectiveness of therapy

Directions to Hospitals Treating Stress cardiomyopathy

Risk calculators and risk factors for Stress cardiomyopathy cost-effectiveness of therapy

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

Template:WH Template:WS